DocuSign Announces Change to Location and Format of 2022 Annual Meeting of Stockholders May 12, 2022 4:03 pm|SAN FRANCISCO, May 12, 2022 /PRNewswire/ — DocuSign (Nasdaq: DOCU) today announced that it will be holding its Annual…
Burns & Levinson Represents Northern Sky Research in Sale to Analysys Mason May 12, 2022 4:03 pm|BOSTON, May 12, 2022 /PRNewswire/ — Burns & Levinson is pleased to announce that it represented client Northern…
VISTA OUTDOOR PARTICIPATING IN UPCOMING INVESTOR CONFERENCES May 12, 2022 4:01 pm|ANOKA, Minn., May 12, 2022 /PRNewswire/ — Vista Outdoor Inc. (NYSE: VSTO), the parent company of 39 renowned…
Following Beyond Meat Earnings, Center for Consumer Freedom Ads Highlight What's Really in Fake Meat May 12, 2022 4:01 pm|WASHINGTON , May 12, 2022 /PRNewswire/ — Today, the Center for Consumer Freedom launched a six-figure advertisement campaign with a…
IM Cannabis Reports Record First Quarter 2022 Financial Results; Revenues Increase 169% YoY to $23.6 Million May 12, 2022 4:01 pm|Gross Profit Increased 37% from Q1 2021 as Operational Efficiencies from Integration Take Hold; Company Expects to Achieve…
Arcellx Provides Business Updates and Reports First Quarter 2022 Financial Results May 12, 2022 4:01 pm|— First patient dosed in the Phase 1 clinical trial evaluating ACLX-001 utilizing groundbreaking ARC-SparX technology in relapsed…
LiqTech International Announces First Quarter 2022 Financial Results May 12, 2022 4:01 pm|BALLERUP, Denmark, May 12, 2022 /PRNewswire/ — LiqTech International, Inc. (NASDAQ: LIQT) (“LiqTech”), a clean technology company that manufactures…
AGNC Investment Corp. Declares Monthly Common Stock Dividend of $0.12 per Common Share for May 2022 May 12, 2022 4:01 pm|BETHESDA, Md., May 12, 2022 /PRNewswire/ — AGNC Investment Corp. (Nasdaq: AGNC) (“AGNC” or the “Company”) announced today…
Co-Diagnostics Reports Solid First Quarter 2022 Financial Results May 12, 2022 4:01 pm|Strong results highlighted by record first quarter revenue of $22.7 million and diluted EPS of $0.34
Sandoz launches first generic pirfenidone in US for patients with idiopathic pulmonary fibrosis, growing its respiratory portfolio May 12, 2022 4:00 pm|